Phensuximide
An anticonvulsant medication used in the treatment of epilepsy
Phensuximide is a medication used primarily in the management of epilepsy, specifically for the treatment of absence seizures. It belongs to the class of drugs known as succinimides, which are used to control seizures by reducing abnormal electrical activity in the brain.
Pharmacology
Phensuximide works by modulating the activity of calcium channels in the central nervous system. This action helps to stabilize neuronal membranes and prevent the spread of seizure activity. As a member of the succinimide class, it shares a similar mechanism of action with other drugs such as ethosuximide.
Clinical Use
Phensuximide is indicated for the treatment of absence seizures, which are characterized by brief, sudden lapses in attention and activity. These seizures are most commonly seen in children and can interfere with learning and daily activities. Phensuximide is often used when other medications, such as ethosuximide, are not effective or cause unacceptable side effects.
Side Effects
Common side effects of phensuximide include drowsiness, dizziness, and gastrointestinal disturbances such as nausea and vomiting. More serious side effects can include blood dyscrasias, such as leukopenia and thrombocytopenia, as well as liver toxicity. Patients taking phensuximide should be monitored regularly for these potential adverse effects.
Chemical Properties
Phensuximide is chemically classified as a succinimide derivative. Its chemical structure is similar to that of other anticonvulsants in its class, featuring a succinimide ring. The structural formula of phensuximide is depicted in the accompanying image.
History
Phensuximide was developed as part of efforts to find effective treatments for epilepsy, particularly for types of seizures that were not well-controlled by existing medications. It was introduced into clinical practice in the mid-20th century and has since been used as an alternative to other anticonvulsants.
Related pages
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Affordable GLP1 shots (generic and brand names) such as
- Wegovy NYC (Semaglutide)
- Zepbound NYC /
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Lowest cost GLP1 weight loss NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
- Prescription weight loss NYC including:
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- NYC medical weight loss
- Philadelphia medical weight loss
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
Tags: Budget glp1 weight loss NYC, Zepbound NYC, Philadelphia medical weight loss, Wegovy NYC, Affordable glp1 shots Philadelphia
Error creating thumbnail:
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian